Latest News
Cordillera Investment Partners has held the final closing of its second fund, Cordillera Investment Fund II, with total commitments of USD362 million, bringing the total AUM of the firm to USD648 million.
The fund was oversubscribed and capitalised by endowments, foundations, family offices, and wealth advisors.
Cordillera specialises in unique and less correlated investment opportunities in areas that it believes remain inefficient, misunderstood, and not over-capitalised. The firm has completed investments in various areas including in music royalties, international arbitration, permanent crops and water rights, boat marinas, broadband spectrum licenses, commercial litigation finance, and environmental markets.
In addition
NorthEdge Capital has appointed experienced dealmaker Kevin O’Loughlin as an Investment Manager, based in Birmingham.
O’Loughlin joins NorthEdge from Deloitte, where he was Assistant Director for three years working on a range of transactions involving privately-owned and publicly-listed companies in the Midlands. These include the sale of Atcore to Inflexion Private Equity, the sale of Aegis Engineering to US buyer Safariland Group and Eddie Stobart’s acquisition of The Pallet Network.
Prior to Deloitte, O’Loughlin worked as part of EY’s Corporate Finance team, where he advised NorthEdge on investments including Ramsdens, the UK’s largest independent pawnbroker, which successfully floated on
Hedgeweek, in partnership with Intralinks, hosted a webinar to present the findings of a global LP survey that sought to determine investor sentiment towards general partners of alternative investment funds.
Why is this? What are the underlying dynamics at work that are impelling institutions to explore direct investments alongside their existing commingled and co-investment allocations? What benefits are they striving for? Which regions are they favoring?
Obviously there are associated risks to this, not least how such activity could impact LPs existing relationships with their GPs. Join the panel as they discuss the implications
Michael Nitka, Managing Director, Credit Investments,
CuraSen Therapeutics, a privately held biotechnology company focussed on developing therapies to treat neurodegenerative diseases, has closed a USD54.5 million Series A financing Led by New Leaf Venture Partners.
The investor syndicate also includes Longitude Capital, funds managed by Tekla Capital Management LLC, Alta Partners, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and Pappas Capital.
CuraSen is developing small molecule drugs targeting a novel mechanism in the brain to alleviate disabling symptoms and modify disease pathology in patients who suffer from less common (orphan) neurodegenerative disorders as well as Parkinson’s Disease and Alzheimer’s Disease. These symptoms include cognition,
Roquette, a specialist in plant-based ingredients for Food, Nutrition and Health markets and a pioneer in new vegetal proteins, and Equinom Ltd, an Israel-based breeding technology company, have signed a partnership agreement for the development and sourcing of new pea varieties with high-protein content.
In addition to this new collaboration, Roquette and Equinom’s current shareholder Fortissimo Capital will jointly invest USD4 million in the company to support its further development. This is the first agreement and investment made by Roquette in Israel. Through this collaboration Roquette is able to be involved on the cutting edge of new non-GMO plant variety
The UK’s first fully-automated fashion manufacturing marketplace Sewport has secured GBP650,000, less than a year after it launched.
Only launched at the end of 2017, and founded by Latvian entrepreneur Boris Hodakel, Sewport has attracted more than 500 manufacturers and suppliers, as well as more than 4,000 brands internationally.
The company connects small to medium sized fashion brands and budding designers with manufacturers at all stages of development, enabling them to bring their designs to life in an easy and cost-effective way. Boris started the company after working with luxury high fashion brands and realising there was a gap
Dow Schofield Watts Angels – the Northern angel network – has completed its second deal, with a GBP300,000 investment in Miribase Limited, the company behind the Shopblocks e-commerce platform.
Over 25 angel investors took part in the funding round, which will be used to accelerate Shopblocks’ revenues by investment in new sales and marketing resources.
The Shopblocks platform provides a hosted website and online shop solution for SMEs. Shopblocks makes it possible for businesses to launch a bespoke website in an easy and cost-effective way. It fills a gap in the market between inflexible, template-based platforms and custom-built websites
By Olivia Munro, EzeCastle Integration – With Cybersecurity Awareness Month steadily approaching in October, there’s no time like the present to evaluate your firm’s IT vulnerabilities and take steps to mitigate these threats. When looking for vulnerabilities in your organisation’s IT, there are questions you can ask yourself to help you pinpoint the vulnerabilities and remediate the findings. Continue reading for 7 questions to ask yourself when beginning to evaluate your IT security.
1. Does my firm know what assets, both hardware and software, are in inventory?
The first step to considering your vulnerabilities is to create a complete inventory of technology
Private equity firm The Riverside Company has added Applied Logic to its Censis Technologies platform.
Headquartered in St Louis, Applied Logic provides software and third-party hardware used in the sterile processing department (SPD) of hospitals and medical facilities. The company’s products assist with SPD workflows, tracking surgical inventory and alerting staff to issues such as insufficient sterilisation and missing items following surgery.
“Given the similarities between the two businesses, the combination of Censis and Applied Logic will create a very innovative offering,” says Riverside Managing Partner Loren Schlachet. “With its blue-chip customer base and compelling recurring revenue model, Applied
Private investment firm Littlejohn & Co has added to its special situations and private equity investment teams with the appointments of Beth Pollack and Thomas Bennet, who have joined the firm as Vice Presidents, and Bart Stout, who has been promoted to Vice President.
Pollack and Stout are part of Littlejohn’s special situations team and Bennet is a member of the private equity team.
“We are excited to welcome Beth to Littlejohn and are pleased to recognise Bart’s contributions to the firm through this promotion,” says Michael Klein, Chief Executive Officer of Littlejohn. “Tom’s decision to rejoin our firm
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
